BSGM · Biosig Technologies Inc

-

Please sign in to comment on BSGM

1 Comment

Admin

4 years, 2 months ago

BioSig Technologies, Inc is currently in a long term downtrend where the price is trading 9.9% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.

BioSig Technologies, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.

Its net income has increased by 30.4% to $-10M since the same quarter in the previous year.

Finally, its free cash flow fell by 53.5% to $-6M since the same quarter in the previous year.

Based on the above factors, BioSig Technologies, Inc gets an overall score of 2/5.

Exchange	OTCQB
CurrencyCode	USD
ISIN	US09073N2018
Sector	Healthcare
Industry	Medical Devices

Target Price	2.5
Market Cap	783M
PE Ratio	None
Beta	1.68
Dividend Yield	None

ABOUT

Biosig Technologies Inc

BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale. The company also designs and develops an online platform for real-world asset (RWA) tokenization. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Los Angeles, California.

BSGM · Biosig Technologies Inc

-

Biosig Technologies Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Biosig Technologies Inc using a moving average strategy